IL13 and inflammation: In addition, Jayaraj et al. [70] have reported that endogenous IL13 controls brain inflammation induced by lipopolysaccharide treatment in rats by inhibiting pro-inflammatory cytokine expression, resulting in an enhancement of neuronal survival [70].